TMR Predominantly Used Off Label With CABG, FDA-Backed Study Shows
This article was originally published in The Gray Sheet
Executive Summary
The preponderance of cases in which transmyocardial revascularization is performed with cardiac artery bypass grafts signals a need for additional research on the off-label procedure, according to a study published in the Nov. 5 Journal of the American College of Cardiology